[A regimen consisting of daunorubicin, cytarabine (Ara-C) and thioguanine, used as an induction treatment for childhood acute myeloid leukemia (AML). ( NCI )]
UMLS (NCI) C0950617Daunorubicin-AraC-Thioguanine Regimen
Daunorubicin-Cytarabine-Thioguanine Regimen
MRC AML10 Study-DAT Regimen
- Therapeutic or Preventive Procedure